Skip to main content
. 2019 Jul 5;157(1):47–60. doi: 10.1016/j.chest.2019.06.015

Table 4.

Change in Lung Function, Chest CT Imaging Phenotypes, and Other Longitudinal Characteristics Over 5 Years in 10 CT Imaging Subtypes

Characteristic No. of Subjects
Moderate to Severe Centrilobular Emphysema

No CT Imaging Abnormality Paraseptal Emphysema Bronchial Disease Small Airway Disease Mild Emphysema Upper Lung Predominant Lower Lung Predominant Diffuse Discordant Visual Discordant Quantitative P Valuea
No. of subjects 1,593 1,060 525 276 1,159 189 22 345 328 112
Change in FEV1, mL 5,013 −203.63 ± 267.65 −246.45 ± 315.32 −186.51 ± 336.40 −150.12 ± 305.45 −223.15 ± 277.94 −246.41 ± 263.71 −175.67 ± 267.17 −234.26 ± 245.17 −221.69 ± 254.25 −287.17 ± 320.44 < .001
Change in FEV1, mL/y 5,013 −36.13 ± 48.06 −43.64 ± 56.54 −32.27 ± 58.68 −26.45 ± 53.14 −39.23 ± 49.51 −45.51 ± 49.40 −35.20 ± 53.76 −41.48 ± 41.06 −38.84 ± 44.88 −50.31 ± 55.59 < .001
Change in GOLD spirometry grade, No. (%) 4,148 < .001
 −1 293 32 (2.9) 50 (6.1) 30 (9.0) 36 (18.1) 90 (10.0) 13 (7.9) 1 (6.7) 15 (5.4) 14 (6.1) 12 (12.2)
 No change 3,140 1,001 (89.8) 562 (69.0) 254 (76.0) 143 (71.9) 649 (71.9) 107 (65.2) 11 (73.3) 191 (69.2) 156 (68.1) 66 (67.3)
 +1 715 82 (7.4) 203 (24.9) 50 (15.0) 20 (10.1) 164 (18.2) 44 (26.8) 3 (20.0) 70 (25.4) 59 (25.8) 20 (20.4)
Change in SGRQ total score 5,194 −0.69 ± 15.08 2.12 ± 16.79 −1.46 ± 19.13 0.60 ± 13.83 0.19 ± 14.29 1.52 ± 12.52 0.13 ± 11.60 4.14 ± 12.75 0.71 ± 16.01 0.24 ± 11.81 < .001
Change in 6-minute walking distance 4,945 −121.00 ± 351.94 −150.05 ± 390.70 −138.73 ± 374.55 −135.34 ± 323.90 −131.36 ± 334.22 −208.92 ± 379.85 −94.87 ± 349.95 −219.47 ± 351.80 −169.96 ± 350.88 −112.24 ± 237.06 < .001
Change in adjusted lung density, g/L 4,744 1.41 ± 13.86 −3.35 ± 13.51 −0.99 ± 15.13 2.65 ± 14.15 2.35 ± 14.24 −4.18 ± 11.93 −10.10 ± 8.66 −1.16 ± 11.28 −5.12 ± 13.51 10.15 ± 12.53 < .001
Change in Perc15 4,744 1.70 ± 17.44 −3.06 ± 15.37 −7.44 ± 24.20 2.62 ± 17.27 1.75 ± 16.15 −4.01 ± 11.84 −8.27 ± 6.77 −1.24 ± 10.04 −7.63 ± 13.92 10.40 ± 13.03 < .001
Change in PRMfSADb 4,020 0.83 ± 4.65 2.16 ± 8.11 2.02 ± 7.99 −1.64 ± 8.64 1.31 ± 9.46 1.66 ± 6.45 0.68 ± 10.25 1.20 ± 7.77 3.60 ± 8.53 −0.64 ± 8.52 < .001
Survival rates, y, No. (%) 7,994 2,130 1,697 734 340 1,544 283 50 643 463 110
 1 7,580 2,018 (94.7) 1,636 (96.4) 699 (95.2) 313 (92.1) 1,456 (94.3) 260 (91.9) 50 (100.0) 593 (92.2) 455 (98.3) 100 (90.9)
 3 7,341 1,990 (93.4) 1,554 (91.6) 684 (93.2) 306 (90.0) 1,430 (92.6) 244 (86.2) 48 (96.0) 545 (84.8) 440 (95.0) 100 (90.9)
 5 6,971 1,948 (91.5) 1,451 (85.5) 666 (90.7) 296 (87.1) 1,379 (89.3) 212 (74.9) 38 (76.0) 460 (71.5) 422 (91.1) 99 (90.0)

Data are mean ± SD unless indicated otherwise. See Tables 1, 2 and 3 legends for expansion of abbreviations.

a

P value tests for differences across all 10 groups.

b

The PRMfSAD of quantitative CT imaging integrates inspiratory and expiratory images to produce relative percentages of functional small airway disease defined by lung area < −856 HU at normal expiration.